If you wish to respond to a paper or other item already published in the BJA, please go to the abstract/full text version of that item and click on the link "E-Letters: Submit a response to the article".
Electronic Letters to:
|
|
E-letters: Electronic letters published:
-
![[Read E-letter]](/icons/misc/sectionDOWN.gif)
Are changes in serum S100B a prognostic index in sepsis associated encephalopathy?
- Ornella Piazza (11 December 2007)
-
Changes in S100B levels rather than absolute values may be a better marker of severity of encephalop
- Joana K. Panni, Moeen K. Panni (20 November 2007)
|
|
|||
|
Ornella Piazza
Send letter to journal:
|
Editor: Dr Joana and Moeen Panni suggest that S100B changes rather than absolute values may be a better marker of severity of sepsis-associated encephalopathy. They assume that comatose patients who have normal S100B values at ICU admission may proceed to higher values later. As previously described (1), our sepsis patients showed alteration of consciousness at admission; they did not develop it during their ICU stay. In our experience (1), S100B was measured at ICU admission and after 3 and 7 days: there was not any correlation with neurological outcome at any time point. Any prognostic marker should be precocious and specific: we respectfully disagree with Dr Panni when they write that the rate of S100B increase after 7 days of coma may add useful information in prognosis formulation but we support the hypothesis that S100B serum levels measured by commercial ELISA kit do not allow the observers to distinguish brain S100B release from peripheral tissues production (2). References 1) Piazza O, Russo E, Cotena S, Esposito G, Tufano R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth. 2007 Oct;99(4):518-21. 2) Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir. 2005 Dec;60(6):477-80. Conflict of Interest:None declared |
|||
|
|
|||
|
Joana K. Panni University of Texas, Moeen K. Panni
Send letter to journal:
|
Editor- We read with interest the article by Piazza and colleagues, where they report that elevated S100B levels did not correlate with the severity of encephalopathy during sepsis (1). We would like to ask the authors that even though the S100B levels did not correlate to the severity of encephalopathy on ICU admission, whether the rate of increase in serum S100B levels could be indicative of severity of encephalopathy. The time of ICU admission is a variable in itself, in terms of when the duration of sepsis began. In fact, a third of the patients, three with GCS scores ≤ 8, had normal range S100B levels at the time of admission. We assume that these values did not remain at normal levels but proceeded to increase. Investigating the rate of change of serum S100B levels at an individual level would allow the removal of inherent individual variation due to sex or to age - which in this study spans 47- 84 years. S100B expression is not restricted to neuronal tissues (2) and serum S100B levels have been shown to be increased after bone fractures (3) or after ischemia of the liver, gut or kidney (4). Therefore S100B may be elevated during sepsis alone, and it may be that the rate of release of serum S100B is higher if there is an underlying encephalopathy, in addition to sepsis. This rate of increase in serum S100B levels may be a more sensitive readout of ongoing pathology, with high rate of increase indicating an underlying brain encephalopathy. In the present study, the average S100B levels seem to be increased at day 7 compared to levels at ICU admission, with a larger spread indicating some patients have lower levels whereas some patients have much higher levels than the average. It would be interesting if this rate of release of S100B was an indicator of prognosis, where if S100B levels are still increasing by day 7, prognosis may be poor and a slight increase or decrease would indicate a better prognosis. References 1) Piazza O, Russo E, Cotena S, Esposito G, Tufano R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 2007; 99:518-21 2) Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest 1987; 57:489-98 3) Undén J, Bellner J, Eneroth M, Alling C, Ingebrigtsen T, Romner B. Raised serum S100B levels after acute bone fractures without cerebral injury. J Trauma 2005; 58:59-61 4) Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 2004; 21:72-6 Conflict of Interest:None declared |
|||